搜索临床试验以:聚乙二醇干扰素
总计831个结果
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)撤销
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research Consortium完全的
-
Eiger BioPharmaceuticalsAnkara University完全的
-
Seng Gee LimMerck Sharp & Dohme LLC; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital 和其他合作者完全的
-
University of MiamiNational Cancer Institute (NCI)终止
-
Janssen R&D Ireland完全的
-
National Cancer Institute (NCI)完全的
-
Third Affiliated Hospital, Sun Yat-Sen UniversityShanghai Jiao Tong University School of Medicine未知
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe Ltd完全的
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research Consortium完全的
-
Biogen完全的
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University招聘中
-
AbbVie (prior sponsor, Abbott)完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
CardresearchMcMaster University; Eiger BioPharmaceuticals; Cytel Inc.; Fastgrants; RainWater Foundation招聘中
-
Bristol-Myers Squibb完全的
-
Children's Oncology GroupNational Cancer Institute (NCI); University College, London; Medical Research Council完全的
-
M.D. Anderson Cancer Center撤销恶性胶质瘤 | 髓母细胞瘤 | 间变性室管膜瘤 | 复发性恶性胶质瘤 | 复发性髓母细胞瘤 | 非典型畸胎瘤样/横纹肌样瘤 | 原始神经外胚层肿瘤 | 脉络丛癌 | 复发性非典型畸胎瘤样/横纹肌样瘤 | 恶性脑肿瘤 | 中枢神经系统生殖细胞肿瘤 | 颅内髓样肉瘤 | 复发性间变性室管膜瘤 | 复发性恶性脑肿瘤 | 复发性原始神经外胚层肿瘤美国